CSL Names Deborah Waterhouse as Chief Executive Officer and Managing Director
Start here
CSL Limited's board has appointed Deborah Waterhouse as Chief Executive Officer and Managing Director, effective February 1, 2027. The announcement, made on October 21, followed a global search conducted by the board. Waterhouse brings more than 25 years of experience and has led global specialty pharmaceutical companies across the United States, Britain, continental Europe and Australia. She will take charge of one of the world's major biotechnology companies at a point of leadership transition. Details of her priorities and any further executive changes have not yet been set out.
Written by a model from the reports · updated 4 min ago
Coverage timeline
Follow the coverage to see the different angles.
- WeChatPickCSL Appoints Deborah Waterhouse as Chief Executive Officer and Managing Director
CSL Limited's board announced on October 21 that Deborah Waterhouse will become Chief Executive Officer and Managing Director from February 1, 2027. Waterhouse has more than 25 years of experience and has led global specialty pharmaceutical companies in the United States, Britain, continental Europe and Australia. The appointment followed a global search conducted by the board.
- BioCenturyCSL, Voyager introduce incoming CEOs
Coverage and heat for this story
Reports so far 3·Heat now 15·Peak heat 17 (Oct 22 12:00)·Reports, 24h +3
Two panels, same clock (pointer stays in sync): top is cumulative editorial reports — only rises; last point = All reports; slope = new reports that hour. Bottom is Live-board heatIndex — 7-day participants with a 24-hour half-life, so it can fall when talk cools.